Alliant Energy / Renewable Energy / Waste Management / Ecological Resources / Technologies LLC / NorthStar Medical Technologies LLC / /
Continent
Europe / /
Country
South Africa / United States / Canada / / /
Event
Environmental Issue / /
Facility
Canadian National Research Universal reactor / Alliant Energy substation / NorthStar facility / /
IndustryTerm
construction site / Heavy equipment / chemical processing area / linac and chemical processing facility / linac and chemical processing equipment / natural gas / selected technologies / accelerator-based technology / protection equipment / chemical processing facility / civilian applications / metal / electricity / linac technology / construction equipment / communications systems / accelerator technology / project site / manufacturing / transportation infrastructure / maximum annual greenhouse gas emissions / chemicals / /
Organization
National Research Council / Final Environmental Assessment Responsible Agency / Wisconsin Department of Natural Resources / U.S. Department of Energy / Council on Environmental Quality / DOE NEPA / Occupational Safety and Health Administration / Jeffrey Chamberlin NEPA Document Manager Office / National Nuclear Security Administration / /
Environmental Assessment for NorthStar Medical Technologies LLC Commercial Domestic Production of the Medical Isotope Molybdenum-99 (DOE/EA–1929)